Vascular endothelial growth factor (VEGF) is a potent endothelial cell mitogen that promotes angiogenesis, vasculogenesis, and increases vascular permeability.
Introduction
Vascular endothelial growth factor (VEGF), also known as vascular permeability factor, is a potent mitogen for endothelial cells and is involved in angiogenesis, vasculogenesis, tumor growth, and embryonic vessel development [1] . Human VEGF is composed of four glyco-proteins, 121-, 165-, 189-, or 206-amino acids subunit [2] . Although VEGF 121 and VEGF 165 exist as soluble secreted forms, VEGF 189 and VEGF 206 are mostly bound to the cell surface or extracellular matrix (ECM) [2] . There are two major VEGF receptors, flt-1 and KDR (also known as flk-1 in mouse) [3, 4] . In fetal human kidney, VEGF localizes to epithelial cells in S-shaped bodies and collecting ducts [5] . In adult kidney, VEGF is expressed in glomerular visceral epithelial cells, epithelial cells of distal tubules and collecting ducts [6] . VEGF may have a role in the induction of proteinuria in renal diseases [6, 7] , and mesangial cells synthesize VEGF in response to fetal bovine serum (FBS) [8] , angiotensin II [9] and transforming growth factor-ß (TGF-ß) [8] . VEGF up-regulation in the mesangium has also been demonstrated in human [8] and experimental mesangioproliferative glomerulonephritis [10] . However, the mechanisms regulating VEGF expression in tubular epithelial cells have not been elucidated. In the present study, we utilized murine renal proximal tubular epithelial cells (mProx24) and identified that TGF-ß 1 potently induced the production of VEGF mediated via the PKC signaling pathway. These findings may potentially serve to clarify the mechanisms involved in the progression of tubulointerstitial alterations observed in various renal disorders.
Methods

Cell Culture
Murine intramedullary collecting duct (mIMCD-3) cells were obtained from American Type Culture Collection. mIMCD-3 cells were cultured in Dulbecco's Modified Eagle's Medium (DMEM) containing 10% FBS and penicillin G (100 U/ml) and 100 Ìg/ml of streptomycin at 37°C in a humidified atmosphere of 5% CO 2 , and used between the 10th and 15th passages. Immortalized murine proximal tubular cells (mProx) derived from microdissected proximal tubular segments of C57BL/6J adult mouse kidney were used as previously described [11] . mProx cells (also termed as mProx24) form confluent monolayer with a cobblestone appearance (data not shown). mProx24 cells are partially polarized with a sparse brush border facing the medium and a basolateral membrane attached to the substratum, and tight junctions are observed at the apical neck under electron microscopy (data not shown). mProx24 cells reabsorb albumin at 37°C, express cytokeratin and lack ·-smooth muscle actin expression [11] . These cells are also positive for E-cadherin, alkaline phosphatase and ZO-1 (data not shown), further indicating the phenotype of mProx24 cells as proximal tubular epithelial origin. mProx cells were cultured in K1 medium composed of 1:1 mixture of DMEM and Ham's F12 culture medium, supplemented with 10% FBS, insulin (5 Ìg/ml), transferrin (5 Ìg/ml), selenious acid (5 ng/ml), hydrocortisone (50 nM ), epidermal growth factor (10 ng/ml), hepatocyte growth factor (25 ng/ml), penicillin G (100 U/ml) and 100 Ìg/ml of streptomycin, and used between the 6th and 15th passages.
Microdissection and Isolation of Various Tubular Segments
The experimental protocol was approved by the Animal Ethics Review Committee of Okayama University Graduate School of Medicine and Dentistry. Normal SD rats (Japan SLC) were anesthetized with sodium pentobarbital, and abdominal aorta was exposed. The left kidney was perfused with solution A (130 mM NaCl, 5 mM KCl, 1 mM Na 2 H 2 PO 4 , 1 mM MgSO 4 , 1 mM calcium lactate, 2 mM sodium acetate, 5.5 mM glucose, and 10 mM Hepes (pH 7.4) containing 0.1% collagenase (Wako) and 0.1% bovine serum albumin (Sigma), and then microdissection of nephron segments was performed in the presence of 10 mM vanadyl ribonucleoside complex (Life Technologies BRL, Gaithersburg, Md., USA) as described previously [12] . Proximal straight tubules (S1, S2 and S3), proximal convoluted tubules, medullary thick ascending limbs and outer medulla collecting duct were obtained. After washing with solution A, nephron segments (2-10 mm) were transferred into microcentrifuge tubes, and 10 Ìl of solution A containing 1 1 U/Ìl RNase inhibitor (Roche) and 1 mM dithiothreitol (Sigma) was added.
Measurement of VEGF Protein Concentration in Culture
Supernatant mProx24 cells were trypsinized and a suspension of 3 ! 10 5 cells in DMEM with 5% FBS was added to each well of a 6-well plate precoated with 0.1% gelatin. The cells were incubated for 24 h at 37°C, and medium was replaced with DMEM supplemented with 0.5% FBS and incubated for 24-48 h. The cells were incubated with serum-free media containing interleukin-1ß (IL-1ß, 100 U/ml; Sigma), lipopolysaccharides (LPS, 1 Ìg/ml; Sigma), angiotensin II (100 nM; Sigma), interleukin-10 (IL-10, 10 Ìg/ml; Sigma), interferon-Á (IFN-Á, 100 IU/ml; Sigma) or TGF-ß 1 (0.1-10 ng/ml; Sigma) and incubated for 24 h. Culture supernatant was obtained and the concentration of mouse VEGF was determined by ELISA using Quantikine M mouse VEGF (R&D Systems) following the manufacturer's instructions. In another set of experiments, cells were incubated with TGF-ß 1 (1 ng/ml) for 24 h in the presence of anti-mouse TGF-ß 1 antibody (polyclonal rabbit IgG, 40 ng/ml; R&D Systems) or control rabbit IgG, and the culture supernatant was processed for ELISA as previously described [13] . All groups represent triplicate samples. These experiments were repeated three times.
Inhibition of Protein Kinase C Pathway
Cells were seeded into each well of 6-well plates and serumstarved as described above. The cells were then pretreated with specific PKC inhibitor, staurosporin (100 nM; Sigma) or Ro-31-8220 (15 ÌM; Calbiochem) for 30 min prior to the addition of TGF-Tß 1 (1 ng/ml). After 24 h, the concentration of VEGF in the culture supernatant was determined using ELISA. All groups represent triplicate samples. These experiments were repeated three times.
Extraction of Total RNA
Cells were seeded into 10-cm culture dishes in DMEM containing 5% FBS, and serum-starved (0.5% FBS, 24 h). The cells were then treated with 0-2 ng/ml of TGF-ß 1 in serum-free media for 8 h. After the washing cells once with PBS, total RNA was extracted using an RNeasy Midi kit (Qiagen, Chatsworth, Calif., USA) following the manufacturer's instructions. The amount of total RNA was quantified spectrophotometrically and standardized according to the intensity of 28S ribosomal RNA (rRNA). In some experiments, cells were incubated with actinomycin D (Sigma) for 2 h following stimulation with TGF-ß 1 .
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Reverse Transcription (RT)-PCR Analysis Using Nephron Segments
RT-PCR was performed using the cDNA synthesis kit and PCR master kit, as previously described [14] . Each sample (nephron segment) was centrifuged at 15,000 rpm for 5 min at 4°C. Supernatant was discarded and 3.5 Ìl of 2% Triton X-100 with RNase inhibitor and dithiothreitol was added. Then, 4.4 Ìl of RT mixture containing random primers was added. The mixture was incubated at 42°C for 60 min. The RT reaction was terminated by heating the samples at 90°C for 5 min. The RT products were amplified with Taq polymerase and specific primer pairs for mouse VEGF (R&D Systems) and glyceraldehyde-3-phosphate dehydrogenase (GAPDH) as described previously [15] . After initial denaturation at 94°C for 4 min, each PCR cycle consisted of denaturation at 94°C for 45 s, annealing at 54°C (VEGF) or 60°C (GAPDH) for 45 s, and extension at 72°C for 45 s followed by 10 min of final extension at 72°C. The samples were amplified 30 cycles in an i-Cycler Thermal Cycler (Bio-Rad). Aliquots of the PCR product were electrophoresed on a 1.4% agarose gel, stained with ethidium bromide, and analyzed under UV light to visualize bands. Expression of various VEGF isoforms was determined by RT-PCR with minor modifications. Briefly, total RNA was reverse transcribed, and then amplified with Taq polymerase and specific mouse VEGF PCR primer pairs using a PCR one-step RT-PCR kit (Takara). The following steps were performed as described above. These experiments were repeated three times with similar results.
Northern Blot Analysis
Total RNA (20 Ìg) was electrophoresed through 1% denaturing formaldehyde-agarose gels and then transferred to a Hybond-N nylon membrane (Amersham Pharmacia Biotech). A 32 P-labeled cDNA probe for mouse VEGF (kindly provided by Dr. Morishita, Osaka, Japan) was generated by using a rediprime II random prime labeling system (Amersham). After ultraviolet cross-linking for 2 min on a UV cross-linker, blots were pre-hybridized for 1 h at 65°C in Rapid-hyb TM buffer (Amersham) and hybridized with the isotopelabeled cDNA probe overnight at 65°C. The blots were then washed twice in 3! SSC (0.45 M NaCl, 45 mM sodium citrate) at room temperature for 15 min, followed by the wash in 1! SSC (0.15 M NaCl, 15 mM sodium citrate), 0.5% Sarcosyl (Nacalai Tesque, Japan) at 65°C with four changes over 1 h. Blots were further washed twice in 0.5! SSC, 0.5% Sarcosyl at 65°C for 15 min. Signal intensity was analyzed with a PhosphoroImager (BAS-1800 Fujifilm). In control experiments, total RNA (1 Ìg) was electrophoresed on 1% formaldehyde-agarose denaturing gels and processed for ethidium bromide staining to visualize 28S rRNA which served as control for equal RNA content in each lane. These experiments were repeated three times.
Statistical Analysis
All values are expressed as mean B SE. ANOVA with a one-tailed Student's t test was used to identify significant differences in multiple comparisons. A level of p ! 0.05 was considered statistically significant. Fig. 1 . Expression of VEGF mRNA in nephron segments. Each nephron segment was isolated from normal rat kidney by microdissection and total RNA was extracted and processed for RT-PCR to detect VEGF mRNA. Among three different splice isoforms of VEGF, VEGF 164 was most highly expressed. S1-3: proximal straight tubules, MAL: medullary thick ascending limb, CD: collecting duct. Aliquots of the PCR products were electrophoresed on a 1.4% agarose gel and visualized by ethidium bromide staining. The amount of GAPDH mRNA in every sample was assessed as control. The arrows indicate the position of the amplified cDNA. The result of densitometric analysis (VEGF/GAPDH ratio) is shown below. This experiment was repeated three times, and the representative data are shown. 
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Results
Expression of VEGF mRNA in Renal Tubular Segments
Segments of renal tubules were isolated from normal rat kidney, and total RNA was extracted and the expression of VEGF mRNA was examined semiquantitatively by RT-PCR. VEGF mRNA was highly expressed in medullary thick ascending limbs and was also mildly expressed in segments (S1-3) derived from proximal tubules as well as collecting ducts ( fig. 1) .
VEGF Isoforms Expressed in mProx24
Expression of different VEGF isoforms in mProx24 was examined by RT-PCR as described in Methods. There are three different murine VEGF isoforms reported previously, VEGF 120 , VEGF 186 and VEGF 164 [16] . In mProx24 cells, all three murine VEGF isoforms were detected by RT-PCR, and VEGF 164 was most abundantly expressed among them ( fig. 2 ). 3B ). In contrast, TGF-ß 1 did not stimulate VEGF production in IMCD-3 cells, suggesting its specific effect on proximal tubular epithelial cells ( fig. 3C ).
VEGF mRNA Expression Is Induced by TGF-ß 1
The effect of TGF-ß 1 on the expression of VEGF mRNA was studied by Northern blot analysis in mProx24. TGF-ß 1 increased the steady-state mRNA level of VEGF in a dose-dependent manner with significant increases observed at a concentration as low as 0.1 ng/ml ( fig. 4A ). The level of VEGF mRNA after TGF-ß 1 treatment was increased at all time points as compared to unstimulated cells and the peak increase was observed after 8 h (fig. 4B ).
Effects of TGF-ß 1 on the Stability of VEGF mRNA
The effect of TGF-ß 1 on the stability of VEGF mRNA was studied. Northern blot analysis was performed with the RNA extracted from cells treated with actinomycin D (5 Ìg/ml) after 8 h of TGF-ß 1 treatment. The level of VEGF mRNA was markedly decreased by incubation 4C ). This result suggests that TGF-ß 1 may not affect the stability of VEGF mRNA.
Anti-TGF-ß 1 Neutralizing Antibody Inhibited the Effect of TGF-ß 1 on VEGF Protein Expression
Induction of VEGF protein expression by TGF-ß 1 was abolished in the presence of neutralizing anti-TGF-ß 1 antibody ( fig. 5A ). Incubation with control rabbit IgG did not show any effect in blocking VEGF expression induced by TGF-ß 1 (data not shown).
Involvement of PKC Pathway in TGF-ß 1 -Induced VEGF Expression
Since the PKC pathway has been reported to play an important role in mediating TGF-ß 1 -induced VEGF expression in other cell types [14] , we investigated the involvement of this pathway in mediating TGF-ß 1 -induced VEGF expression using mProx24 cells. Cells were incubated with TGF-ß 1 in the presence of selective PKC inhibitors, Ro-31-8220 or staurosporin. The appearance of cells under light microscopy was not altered in the presence of selective PKC inhibitors (data not shown). Both Ro-31-8220 and staurosporin significantly suppressed TGF-ß 1 -induced VEGF expression (TGF-ß 1 : 817.5 B 27.9 pg/ml, TGF-ß 1 and Ro-31-8220: 0.67 B 0.74 pg/ml, TGF-ß 1 and staurosporin: 79.3 B 27.1 pg/ml) ( fig. 5B) . These results suggest that VEGF expression induced by TGF-ß 1 is mainly mediated via the PKC signaling pathway. Effects of anti-TGF-ß 1 neutralizing antibody and protein kinase C inhibitors on the expression of VEGF protein induced by TGF-ß 1 . mProx24 cells were treated with TGF-ß 1 (2 ng/ml) in the presence of neutralizing anti-TGF-ß 1 antibody for 24 h. VEGF protein expression induced by TGF-ß 1 was abolished in the presence of neutralizing anti-TGF-ß 1 antibody. Anti-TGF-ß 1 antibody alone as well as control IgG (data not shown) showed no effect on the VEGF level (A). mProx24 cells were pretreated with 15 ÌM of Ro-31-8220 or 100 nM of staurosporin for 30 min followed by the addition of TGF-ß 1 (2 ng/ml). Both PKC inhibitors significantly suppressed TGF-ß 1 -induced VEGF expression (B). The concentration of VEGF 164 protein in the culture supernatant was measured by ELISA as described in Methods (A, B) . Each column represents the mean B SE of triplicate wells. This experiment was repeated three times with similar results, and the representative data are shown. * p ! 0.01 and ** p ! 0.001 by one-tailed Student's t test. 
Discussion
The progression of human renal disorders to end-stage renal failure after an initial insult is a phenomenon remaining largely unexplained. Previous studies suggest that tubulointerstitial changes, not histological alterations of the glomeruli, correlate better with deterioration of the renal function in various renal diseases [17] . Tubular epithelial cell atrophy, interstitial mononuclear cell infiltration and interstitial fibrosis are the characteristic histological features observed in tubulointerstitial lesions [17] . Among various proteins, TGF-ß 1 is a key molecule involved in the progression of renal interstitial fibrosis and glomerulosclerosis [18] .
Angiogenesis, the development of new blood vessels from pre-existing ones, is involved in the normal physiological events as well as pathological disorders [19] [20] [21] .
VEGF is an established angiogenic growth factor and is also known as vascular permeability factor [22] . The predominant isoform of VEGF produced in mProx24 was VEGF 164 , known to possess most potent biological activities [22] . Bates et al. [23] reported the identification of novel inhibitory VEGF isoform, VEGF 165 b abundantly expressed in normal human kidney. Since VEGF primer pairs used in our study recognize mouse VEGF 120 , VEGF 186 and VEGF 164 isoforms, it is possible that murine VEGF isoform corresponding to human VEGF 165 b was not detected. Alternatively, there may be differences among species (mouse and human) and murine VEGF isoform corresponding to human VEGF 165 b may not be formed. In general, expression of VEGF is induced by hypoxia, growth factors and cytokines, and is involved in the vasculogenesis and nephrogenesis [2] . A previous report demonstrated that hypoxia did not stimulate VEGF gene expression in kidney in vivo [24] , suggesting the involvement of distinct regulatory mechanism other than hypoxia in producing VEGF in vivo. Accordingly, in the present study, we examined the stimulatory effect of various cytokines or growth factors on inducing the expression of VEGF. VEGF induces a proliferative and an anti-apoptotic response in renal tubular epithelial cells [25] . In normal adult kidney, VEGF is expressed mainly in distal tubules and collecting ducts [26] , consistent with our results using nephron segments obtained by microdissection. Upon stimulation by TGF-ß 1 , marked up-regulation of VEGF was observed in mProx24 cells, although such induction was not observed in epithelial cells derived from collecting ducts (mIMCD-3 cells). Interestingly, mProx24 cells did not respond to other growth factors or cytokines known to induce VEGF expression in other cell types. Kang et al. [26] demonstrated that IL-1ß, IL-6 and TNF-· inhibited VEGF mRNA and protein expression using tubular epithelial cells of the medullary thick ascending limb, suggesting the diverse response to inflammatory stimuli depending on the origin of nephron segments. Induction of VEGF in response to TGF-ß 1 was confirmed at mRNA as well as at protein levels detected by Northern blot analysis and ELISA, respectively. The effect of TGF-ß 1 in inducing VEGF was dose-and timedependent. Increased VEGF mRNA level after TGF-ß 1 stimulation is most likely due to the transcriptional activation rather than altering the half-life of VEGF mRNA, since the addition of TGF-ß 1 failed to affect the degradation of VEGF mRNA as demonstrated by our experiments using actinomycin D. The specific effect of TGF-ß 1 in inducing VEGF was further confirmed using neutralizing anti-TGF-ß 1 antibody.
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Previous studies demonstrated the involvement of various signal transduction pathways in the biological activities of TGF-Tß 1 [27] . These intracellular signaling pathways include the smad family of proteins, protein kinase A and MAPK pathways. The involvement of PKC pathway in TGF-ß 1 signaling leading to VEGF expression using osteoblasts [14] , prompted us to investigate the involvement of this pathway also in mProx24. PKC inhibitors almost totally abolished the VEGF protein expression in response to TGF-ß 1 treatment, indicating the predominant involvement of the PKC pathway. However, it is also possible that other signaling pathways indirectly affect the induction of PKC through cross-talk after stimulation by TGF-ß 1 .
Recent reports demonstrated the protective role of VEGF administration in the remnant kidney and thrombotic microangiopathy model [28, 29] . The improvement of the renal histological changes (interstitial fibrosis) was correlated with increased peritubular capillary densities suggesting the role of VEGF in inducing angiogenesis in the interstitium through binding to VEGF receptors on peritubular capillary endothelial cells. Another wellknown function of VEGF is increasing vascular permeability. The ear skin of mice overexpressing VEGF is thickened, consistent with the presence of tissue edema due to the increased vascular permeability induced by VEGF [30] . These previous findings suggest a possibility that VEGF up-regulation induced by TGF-ß 1 in proximal tubular epithelial cells may promote inflammatory cell infiltration in the interstitium resulting in interstitial fibrosis through altering the vascular integrity of peritubular capillaries resulting in the 'leaky' blood vessels. This hypothesis regarding the 'dark' side of VEGF needs further analysis using an in vivo model with renal tubulointerstitial lesions.
In conclusion, we demonstrated that TGF-Tß 1 up-regulated the expression of VEGF in murine renal tubular epithelial cells mainly mediated via the PKC pathway. Further analysis is underway to clarify the role of VEGF induced by TGF-Tß 1 employing an animal model of renal tubulointerstitial injury.
